Medicare is covering Wegovy, a new $4 million drug, and AstraZeneca bets $2 billion: pharma news round up

0
12

Medicare is now covering the popular weight loss drug Wegovy, but not for its slimming benefits. Orchard Therapeutics set the price for a new gene therapy at over $4 million, making it the most expensive drug in the world. And AstraZeneca announced it’s acquiring a next-gen cancer treatment maker for $2 billion.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here